Literature DB >> 16018433

Dynamics of hemodialysis catheter colonization by coagulase-negative staphylococci.

Christoph A Fux1, Dominik Uehlinger, Thomas Bodmer, Sara Droz, Claudine Zellweger, Kathrin Mühlemann.   

Abstract

OBJECTIVES: Catheter colonization is a necessary but poorly characterized step in the pathogenesis of catheter-related infections. Colonization dynamics of central venous hemodialysis catheters were studied with emphasis on coagulase-negative staphylococci (CoNS) and their population genetics, antibiotic resistance, and biofilm formation. The homogeneity of CoNS colony morphotypes was evaluated.
DESIGN: Prospective, longitudinal study during 1,158 catheter-days with microbiological analysis of skin swabs, weekly catheter blood and brush samples, and catheter tips.
SETTING: Hemodialysis unit of a university hospital. PATIENTS: Twenty-six patients with 24 non-tunneled and 5 tunneled catheters.
RESULTS: Nineteen (65.5%) of the catheters became colonized, 17 by CoNS. CoNS colonization of the inner lumen was observed in 17.2% of the catheters and was first detectable after 3 weeks. Colonization of the outer surface occurred in 44.8% of the catheters within a minimum of 2 weeks. PFGE of 53 CoNS revealed 10 clones and 20 unique isolates. Isolates from clones were more frequent in catheter blood and brush cultures than were unique isolates (41% vs 15%), were resistant to more antibiotics (median, 7 vs 2), and tended to more often carry the icaA gene (64.1% vs 40%). Four (23.5%) of the catheters showed colonization with a mixture of CoNS based on PFGE. The time from catheter insertion to such mixed CoNS colonization was longer than that for colonization with one CoNS PFGE pattern only (42 vs 25 days).
CONCLUSIONS: Colonization of hemodialysis catheters is dominated by multidrug-resistant, icaA-positive CoNS clones. Mixed CoNS colonization occurs, but is delayed, suggesting a process of sequential superinfection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018433     DOI: 10.1086/502586

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  6 in total

1.  Identification of Staphylococcus species directly from positive blood culture broth by use of molecular and conventional methods.

Authors:  Maitry S Mehta; Suzanne M Paule; Richard B Thomson; Karen L Kaul; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

2.  Quasi-experimental study of sodium citrate locks and the risk of acute hemodialysis catheter infection among critically ill patients.

Authors:  Jean-Jacques Parienti; Stéphanie Deryckère; Bruno Mégarbane; Xavier Valette; Amélie Seguin; Bertrand Sauneuf; Jean-Paul Mira; Bertrand Souweine; Vincent Cattoir; Cédric Daubin; Damien du Cheyron
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

3.  The bacterial colonization in tunneled cuffed dialysis catheter and its effects on residual renal function in incident hemodialysis patients.

Authors:  Jin Suk Kang; Hee Ryeong Jang; Jeong Eun Lee; Young Joo Park; Harin Rhee; Eun Young Seong; Ihm Soo Kwak; Il Young Kim; Dong Won Lee; Soo Bong Lee; Sang Heon Song
Journal:  Clin Exp Nephrol       Date:  2015-07-30       Impact factor: 2.801

4.  Protein resistance efficacy of PEO-silane amphiphiles: Dependence on PEO-segment length and concentration.

Authors:  Marc A Rufin; Mikayla E Barry; Paige A Adair; Melissa L Hawkins; Jeffery E Raymond; Melissa A Grunlan
Journal:  Acta Biomater       Date:  2016-06-03       Impact factor: 8.947

5.  Clonal dissemination of Staphylococcus epidermidis in an oncology ward.

Authors:  Kenneth L Muldrew; Yi-Wei Tang; Haijing Li; Charles W Stratton
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

6.  Extensive Horizontal Gene Transfer within and between Species of Coagulase-Negative Staphylococcus.

Authors:  Joshua T Smith; Cheryl P Andam
Journal:  Genome Biol Evol       Date:  2021-09-01       Impact factor: 3.416

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.